GMI
BSX icon

Greystone Managed Investments’s Boston Scientific BSX Stock Holding History

Greystone Managed Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.71M Sell
213,950
-8,810
-4% -$373K 0.53% 61
2019
Q2 		$9.57M Buy
222,760
+42,100
+23% +$1.62M 0.55% 57
2019
Q1 		$6.93M Sell
180,660
-12,550
-6% -$479K 0.41% 72
2018
Q4 		$6.83M Buy
193,210
+4,580
+2% +$166K 0.43% 74
2018
Q3 		$7.26M Buy
+188,630
New +$6.59M 0.39% 77

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Greystone Managed Investments's BSX Position: Q3 2019 in Review

Greystone Managed Investments reduced its Boston Scientific (BSX) stake by 4% in Q3 2019, selling an estimated $373K and leaving 213,950 shares worth $8.71M. The position accounts for 0.53% of the portfolio, ranked #61.

Greystone Managed Investments first reported a position in BSX in Q3 2018 and has held it in 5 quarters since. The position peaked at $9.57M in Q2 2019. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Greystone Managed Investments held 213,950 shares of Boston Scientific worth $8.71M as of Q3 2019.
  • Greystone Managed Investments sold 8,810 Boston Scientific shares in Q3 2019, an estimated $373K.
  • Boston Scientific made up 0.53% of Greystone Managed Investments's portfolio in Q3 2019, its #61 holding.
  • Greystone Managed Investments first reported a position in Boston Scientific in Q3 2018 and has held it in 5 quarters since.
  • Greystone Managed Investments's Boston Scientific position peaked at $9.57M in Q2 2019.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Greystone Managed Investments's 13F filing for Q3 2019, filed 5 Nov 2019.